Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Dare Bioscience, Inc. (DARE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 698.00 thousand shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2019-11-12
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 135.00K shares, a 3133.53% increase year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 563.00K shares, a 15985.71% increase year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 1.06M shares, a 576.93% increase year-over-year.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 565.37K shares.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 2.36M shares, a 107.41% increase from fiscal 2014.
- Dare Bioscience, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 1.14M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 7 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 135.00K shares derived: sum of 2 quarters · filed 2019-11-12 | 698.00K shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 135.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 698.00K shares 10-Q · filed 2019-08-14 | |||||
| 2019-03-31 | 563.00K shares 10-Q · filed 2019-05-14 | ||||||
| 2018-09-30 | 1.06M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 1.06M shares derived: sum of 2 quarters · filed 2018-11-13 | 1.07M shares 10-Q · filed 2018-11-13 | 1.48M shares derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2018-06-30 | 4.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 7.67K shares 10-Q · filed 2018-08-13 | 416.70K shares derived: sum of 3 quarters · filed 2018-08-13 | 573.05K shares derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2018-03-31 | 3.50K shares 10-Q · filed 2018-05-14 | 412.52K shares derived: sum of 2 quarters · filed 2018-05-14 | 568.87K shares derived: sum of 3 quarters · filed 2018-05-14 | -910.58K shares derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2017-12-31 | 409.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | 565.37K shares derived: sum of 2 quarters · filed 2018-03-28 | -914.08K shares derived: sum of 3 quarters · filed 2018-03-28 | 565.37K shares 10-K · filed 2018-03-28 | |||
| 2017-09-30 | 156.35K shares derived: 10-Q 9 month − 8-K/A 6 month · filed 2017-11-13 | -1.32M shares derived: sum of 2 quarters · filed 2017-11-13 | 156.35K shares 10-Q · filed 2017-11-13 | -1.41M shares derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2017-06-30 | -1.48M shares derived: 8-K/A 6 month − 10-Q 3 month · filed 2017-10-02 | 0.00 shares 8-K/A · filed 2017-10-02 | 147.94K shares 10-Q · filed 2017-08-14 | -1.57M shares derived: sum of 3 quarters · filed 2017-10-02 | -707.07K shares derived: sum of 4 quarters · filed 2017-10-02 | ||
| 2017-03-31 | 1.48M shares 10-Q · filed 2017-05-12 | -90.62K shares derived: sum of 2 quarters · filed 2017-10-02 | 772.38K shares derived: sum of 3 quarters · filed 2017-10-02 | 932.38K shares derived: sum of 4 quarters · filed 2017-10-02 | |||
| 2016-12-31 | -1.57M shares derived: 8-K/A 12 month − 10-Q 9 month · filed 2017-10-02 | -707.07K shares derived: sum of 2 quarters · filed 2017-10-02 | -547.07K shares derived: sum of 3 quarters · filed 2017-10-02 | 0.00 shares 8-K/A · filed 2017-10-02 | 1.60M shares 10-K · filed 2017-03-31 | ||
| 2016-09-30 | 863.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 1.02M shares derived: sum of 2 quarters · filed 2016-11-03 | 1.57M shares 10-Q · filed 2016-11-03 | 2.56M shares derived: sum of 4 quarters · filed 2016-11-03 | |||
| 2016-06-30 | 160.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 707.07K shares 10-Q · filed 2016-08-04 | 1.69M shares derived: sum of 3 quarters · filed 2016-08-04 | 1.87M shares derived: sum of 4 quarters · filed 2016-08-04 | |||
| 2016-03-31 | 547.07K shares 10-Q · filed 2016-05-02 | 1.53M shares derived: sum of 2 quarters · filed 2016-05-02 | 1.71M shares derived: sum of 3 quarters · filed 2016-05-02 | 2.06M shares derived: sum of 4 quarters · filed 2016-05-02 | |||
| 2015-12-31 | 985.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | 1.17M shares derived: sum of 2 quarters · filed 2016-03-10 | 50.00K shares 8-K/A · filed 2017-10-02 | 1.52M shares derived: sum of 3 quarters · filed 2016-03-10 | 2.36M shares 10-K · filed 2016-03-10 | ||
| 2015-09-30 | 181.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | 532.74K shares derived: sum of 2 quarters · filed 2015-11-16 | 1.38M shares 10-Q · filed 2015-11-16 | 1.70M shares derived: sum of 4 quarters · filed 2015-11-16 | |||
| 2015-06-30 | 351.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 1.19M shares 10-Q · filed 2015-08-06 | 1.52M shares derived: sum of 3 quarters · filed 2015-08-06 | 1.59M shares derived: sum of 4 quarters · filed 2015-08-06 | |||
| 2015-03-31 | 842.82K shares 10-Q · filed 2015-05-06 | 1.17M shares derived: sum of 2 quarters · filed 2015-05-06 | 1.24M shares derived: sum of 3 quarters · filed 2015-05-06 | 1.82M shares derived: sum of 4 quarters · filed 2015-05-06 | |||
| 2014-12-31 | 328.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | 392.26K shares derived: sum of 2 quarters · filed 2015-03-19 | 978.56K shares derived: sum of 3 quarters · filed 2015-03-19 | 1.14M shares 10-K · filed 2015-03-19 | |||
| 2014-09-30 | 64.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | 650.36K shares derived: sum of 2 quarters · filed 2014-11-13 | 809.97K shares 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | 586.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 745.91K shares 10-Q · filed 2014-08-12 | |||||
| 2014-03-31 | 159.61K shares 10-Q · filed 2014-05-27 | ||||||
| 2013-09-30 | 0.00 shares 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |